Columvi-2.5mg/2.5ml (Glofitamab-gxbm Vials) 2.5 mg/2.5 mL

Columvi (glofitamab-gxbm) 2.5 mg/2.5 mL is a prescription monoclonal antibody used in cancer therapy. This vial form targets specific cancer cells for targeted treatment. It is designed for intravenous use under medical supervision. Always consult a healthcare provider for proper administration.

Strength

2.5 mg/2.5 mL

Manufacturer / TM Owner

Roche Products Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Columvi (glofitamab-gxbm) 2.5 mg/2.5 mL is used to treat certain types of cancer, including relapsed or refractory diffuse large B-cell lymphoma. It belongs to a class of medications called bispecific antibodies, which help the immune system recognize and attack cancer cells. This medication is typically given when other treatments have not been effective. It is not a first-line therapy and requires medical oversight.

Side Effects

Columvi (glofitamab-gxbm) 2.5 mg/2.5 mL works by binding to cancer cells and immune cells, helping the immune system target and destroy the cancer. Patients may experience immune-related effects as the body responds to treatment. Common effects include fatigue, fever, and reactions at the injection site. These effects vary by individual and should be monitored by a healthcare professional.

Precautions & Warnings

Columvi (glofitamab-gxbm) 2.5 mg/2.5 mL should only be handled and administered by trained medical professionals. It is important to follow all safety guidelines, including proper storage and disposal of vials. Patients should report any signs of infection, fever, or unusual symptoms immediately. Pregnant or breastfeeding individuals should discuss risks with their doctor before use.

Avoid Interactions

Columvi (glofitamab-gxbm) 2.5 mg/2.5 mL may interact with other medications that affect the immune system, such as corticosteroids or immunosuppressants. Live vaccines should be avoided during treatment due to potential risks. Patients should inform their healthcare provider about all medications, supplements, and herbal products they are using. Close monitoring is recommended during combined therapies.

Frequently Asked Questions

Columvi (glofitamab-gxbm) is used to treat certain types of cancer, including relapsed or refractory diffuse large B-cell lymphoma.

Columvi is given as an intravenous infusion under the supervision of a healthcare professional.

Common effects may include fatigue, fever, and reactions at the injection site. Always consult a doctor for personalized advice.

Inform your healthcare provider about all medications you are taking, as interactions may occur. Avoid live vaccines during treatment.

Pregnant individuals should discuss potential risks with their doctor before using Columvi.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.